Velsera
Pre-clinicalVelsera accelerates precision medicine development and delivery with AI-enhanced software and expert services for multimodal data analysis, IVD validation, clinical NGS reporting, and drug discovery workflows.
Founded
2023
Focus
DiagnosticsGenetics & GenomicsAI / Machine Learning
About
Velsera accelerates precision medicine development and delivery with AI-enhanced software and expert services for multimodal data analysis, IVD validation, clinical NGS reporting, and drug discovery workflows.
Funding History
1Total raised: $150M
Series A$150MNovalis LifeSciencesJan 15, 2023
Company Info
TypePrivate
Founded2023
LocationCambridge, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile